RATIONALE: Depletion of monocytes reduces LPS-induced lung inflammation in mice, suggesting monocytes as potential therapeutic targets in acute lung injury. OBJECTIVES: To investigate whether depletion of circulating blood monocytes has beneficial effects on markers of systemic and pulmonary inflammation in a human model of acute lung inflammation. METHODS: A total of 30 healthy volunteers were enrolled in a randomized controlled trial. Volunteers inhaled LPS at baseline, and were randomized to receive active mononuclear cell depletion by leukapheresis, or sham leukapheresis, in a double-blind fashion (15 volunteers per group). Serial blood counts were measured, bronchoalveolar lavage (BAL) was performed at 9 hours, and [(18)F]fluorodeoxyglucose positron emission tomography at 24 hours. The primary endpoint was the increment in circulating neutrophils at 8 hours. MEASUREMENTS AND MAIN RESULTS: As expected, inhalation of LPS induced neutrophilia and an up-regulation of inflammatory mediators in the blood and lungs of all volunteers. There was no significant difference between the depletion and sham groups in the mean increment in blood neutrophil count at 8 hours (6.16 × 10(9)/L and 6.15 × 10(9)/L, respectively; P = 1.00). Furthermore, there were no significant differences in BAL neutrophils or protein, positron emission tomography-derived measures of global lung inflammation, or cytokine levels in plasma or BAL supernatant between the study groups. No serious adverse events occurred, and no symptoms were significantly different between the groups. CONCLUSIONS: These findings do not support a role for circulating human monocytes in the early recruitment of neutrophils during LPS-mediated acute lung inflammation in humans.
RCT Entities:
RATIONALE: Depletion of monocytes reduces LPS-induced lung inflammation in mice, suggesting monocytes as potential therapeutic targets in acute lung injury. OBJECTIVES: To investigate whether depletion of circulating blood monocytes has beneficial effects on markers of systemic and pulmonary inflammation in a human model of acute lung inflammation. METHODS: A total of 30 healthy volunteers were enrolled in a randomized controlled trial. Volunteers inhaled LPS at baseline, and were randomized to receive active mononuclear cell depletion by leukapheresis, or sham leukapheresis, in a double-blind fashion (15 volunteers per group). Serial blood counts were measured, bronchoalveolar lavage (BAL) was performed at 9 hours, and [(18)F]fluorodeoxyglucose positron emission tomography at 24 hours. The primary endpoint was the increment in circulating neutrophils at 8 hours. MEASUREMENTS AND MAIN RESULTS: As expected, inhalation of LPS induced neutrophilia and an up-regulation of inflammatory mediators in the blood and lungs of all volunteers. There was no significant difference between the depletion and sham groups in the mean increment in blood neutrophil count at 8 hours (6.16 × 10(9)/L and 6.15 × 10(9)/L, respectively; P = 1.00). Furthermore, there were no significant differences in BAL neutrophils or protein, positron emission tomography-derived measures of global lung inflammation, or cytokine levels in plasma or BAL supernatant between the study groups. No serious adverse events occurred, and no symptoms were significantly different between the groups. CONCLUSIONS: These findings do not support a role for circulating human monocytes in the early recruitment of neutrophils during LPS-mediated acute lung inflammation in humans.
Authors: Konrad Peukert; Mario Fox; Susanne Schulz; Caroline Feuerborn; Stilla Frede; Christian Putensen; Hermann Wrigge; Beate Mareike Kümmerer; Sascha David; Benjamin Seeliger; Tobias Welte; Eicke Latz; Dennis Klinman; Christoph Wilhelm; Folkert Steinhagen; Christian Bode Journal: Am J Respir Crit Care Med Date: 2021-07-01 Impact factor: 21.405
Authors: Mairi Brittan; Laura C Barr; Niall Anderson; Andrew Conway Morris; Rodger Duffin; John A Marwick; Fiona Rossi; Shonna Johnson; Kev Dhaliwal; Nikhil Hirani; Adriano G Rossi; A John Simpson Journal: J Inflamm (Lond) Date: 2014-03-31 Impact factor: 4.981
Authors: John D Widdrington; Aurora Gomez-Duran; Angela Pyle; Marie-Helene Ruchaud-Sparagano; Jonathan Scott; Simon V Baudouin; Anthony J Rostron; Penny E Lovat; Patrick F Chinnery; A John Simpson Journal: Front Immunol Date: 2018-09-27 Impact factor: 7.561
Authors: Laura Jardine; Sarah Wiscombe; Gary Reynolds; David McDonald; Andrew Fuller; Kile Green; Andrew Filby; Ian Forrest; Marie-Helene Ruchaud-Sparagano; Jonathan Scott; Matthew Collin; Muzlifah Haniffa; A John Simpson Journal: Nat Commun Date: 2019-04-30 Impact factor: 14.919
Authors: Alastair Proudfoot; Andrew Bayliffe; Cecilia M O'Kane; Mark Griffiths; Charlotte Summers; Daniel Francis McAuley; Tracey Wright; Adrian Serone; Philippe Jean Bareille; Vanessa Brown; Umar I Hamid; Younan Chen; Robert Wilson; Joanna Cordy; Peter Morley; Ruud de Wildt; Stuart Elborn; Matthew Hind; Edwin R Chilvers Journal: Thorax Date: 2018-01-29 Impact factor: 9.102